南微医学 (688029.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(南微医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2022年第三季度2022年第二季度2022年第一季度2021年第四季度2021年第三季度2021年第二季度2021年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 551,809,768.89517,601,645.53442,690,227.21557,770,178.46514,226,898.47481,208,059.68393,518,815.47
 营业收入(元) 551,809,768.89517,601,645.53442,690,227.21557,770,178.46514,226,898.47481,208,059.68393,518,815.47
二、营业总成本(元) 435,292,455.66418,529,294.48393,863,563.17492,408,444.52419,748,753.47390,654,260.88318,764,464.08
 营业成本(元) 215,381,369.21210,059,754.83169,560,905.68204,113,342.80191,574,901.99169,131,444.25132,470,645.43
 研发费用(元) 37,900,585.5743,191,314.1040,606,208.5251,866,296.5341,998,257.6331,465,864.6927,561,258.83
 营业税金及附加(元) 5,613,367.193,027,213.393,562,243.814,000,369.473,980,884.304,276,636.393,960,243.62
 销售费用(元) 115,361,810.39103,762,248.6088,706,290.84134,936,606.2992,767,321.7788,784,678.7072,071,254.55
 管理费用(元) 89,659,938.3785,264,372.0985,584,445.6883,659,132.8390,267,899.1989,378,654.5282,465,415.02
 财务费用(元) -28,624,615.07-26,775,608.535,843,468.6413,832,696.60-840,511.417,616,982.33235,646.63
  其中:利息费用(元) 649,905.07-39,885.17195,151.63-78,544.85227,355.59--
  其中:利息收入(元) 4,685,942.761,797,771.932,359,580.402,235,677.203,732,716.901,176,146.482,443,579.75
 资产减值损失(元) -3,428,279.02-5,830,442.00-928,587.71-9,616,390.35-6,880,086.57-6,702,715.54690,694.17
 信用减值损失(元) -756,114.28-664,143.56-261,711.49-469,534.23-177,547.94-702,929.00-630,833.00
三、其他经营收益
 加:公允价值变动收益(元) -5,752,648.47------
 加:投资收益(元) 13,474,748.965,132,987.213,968,482.5810,195,230.4141,695,047.837,331,799.716,165,430.60
  其中:对联营企业和合营企业的投资收益(元) 3,960,310.202,376,055.133,370,581.394,175,906.044,119,270.994,773,245.133,471,671.74
 资产处置收益(元) -236.28--1,030,953.43-13,063.69753,174.174,561.961,244.25
 其他收益(元) --293,363.18--46,274.77346,450.06
四、营业利润(元) 120,054,784.14105,399,363.8150,867,257.1765,457,976.08129,868,732.4990,530,790.7081,327,337.47
 加:营业外收入(元) 2,707,731.05594,154.301,150,782.297,108,661.491,027,262.892,641,892.052,183,981.51
 减:营业外支出(元) 185,105.754,849,373.66249,013.022,213,212.49129,168.95412,844.1746,636.62
五、利润总额(元) 122,577,409.44101,144,144.4551,769,026.4470,353,425.08130,766,826.4392,759,838.5883,464,682.36
 减:所得税费用(元) 18,745,640.5116,694,584.506,253,990.62-2,366,595.6221,825,794.2613,671,720.1414,861,974.79
六、净利润(元) 103,831,768.9384,449,559.9545,515,035.8272,720,020.70108,941,032.1779,088,118.4468,602,707.57
(一)按经营持续性分类
  持续经营净利润(元) 103,831,768.9384,449,559.9545,515,035.8272,720,020.70108,941,032.1779,088,118.4468,602,707.57
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 102,108,506.7781,477,004.7843,373,430.7476,221,931.30105,241,866.3976,438,528.8566,848,213.45
  少数股东损益(元) 1,723,262.162,972,555.172,141,605.08-3,501,910.603,699,165.782,649,589.591,754,494.12
 扣除非经常性损益后的净利润(元) 97,122,881.4276,362,098.9842,934,651.4867,752,356.6272,500,010.7472,396,897.9062,973,483.44
七、每股收益
 一、基本每股收益(元) 0.550.340.320.570.790.570.50
 二、稀释每股收益(元) 0.540.340.320.540.790.570.50
八、其他综合收益(元) -759,694.61-249,994.351,295,935.13-4,293,319.75-84,355.95-1,745,829.92-444,937.24
 归属于母公司股东的其他综合收益(元) -751,369.34-250,827.611,295,935.13-4,295,309.53-84,355.95-1,745,829.92-444,937.24
 归属于少数股东的其他综合收益(元) -8,325.27------
九、综合收益总额(元) 103,072,074.3284,199,565.6046,810,970.9568,426,700.95108,856,676.2277,342,288.5268,157,770.33
 归属于母公司所有者的综合收益总额(元) 101,357,137.4381,226,177.1744,669,365.8771,926,621.77105,157,510.4474,692,698.9366,403,276.21
 归属于少数股东的综合收益总额(元) 1,714,936.892,973,388.432,141,605.08-3,499,920.823,699,165.782,649,589.591,754,494.12
公告日期 2022-10-282022-08-192022-04-262022-04-262021-10-282021-08-262021-04-20
审计意见(境内) 标准无保留意见

前瞻产业研究院